Clinical Trial

Evaluation of the Health Effects of the Air Purifier in Preterm Infants After Discharge

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Participant's baby was born prematurely and had underdeveloped lungs at birth. Most premature infants require mechanical ventilation after birth, which increases the risk of lung injury and may lead to varying degrees of bronchopulmonary dysplasia (BPD). Investigators believe that introducing an air purifier into your home environment after Participant's baby is discharged could help improve their lung development. This study aims to non-invasively measure baby's transcutaneous carbon dioxide (PtcCO₂) levels and blood oxygen saturation (SpO₂) at home, both with and without the use of an air purifier. In addition, investigators will collect data from Kaohsiung Medical University Hospital medical records regarding the number of visits, respiratory status, height, weight, head circumference, and developmental progress. Health questionnaires will also be administered to assess changes in health outcomes and provide recommendations on improving indoor air quality in Participant's home.
Trial Details
NCT Number NCT07236996
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Premature - Weight 1000g-2499g or Gestation of 28-37weeks, Premature Birth
Enrollment 180 participants
Start Date 2021-05-21
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-19